Merck & Co To Break New Ground With Female-Led Organon Unit

Former Chair And CEO Of Humacyte, Carrie Cox To Serve As Chair

 
• By Dean Rudge
  
Merck
Merck aims to complete the planned spin-off of its Organon unit “late in the second quarter." • Source: Shutterstock

More from Strategy

More from Business